Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019: A Randomized, Controlled TrialSammy Huygens, Jarom Heijmans, Peter A W te Boekhorst et al.|The Journal of Infectious Diseases|2022Cited by 27
SARS-CoV-2 hyperimmune globulin for severely immunocompromised patients with COVID-19: a randomised, controlled, double-blind, phase 3 trialSammy Huygens, Jarom Heijmans, Grigorios Papageorgiou et al.|medRxiv|2022Cited by 1